Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Verici Dx Plc ( (GB:VRCI) ) is now available.
Verici Dx Plc has announced a change in the voting rights structure, with Maven Capital Partners UK LLP now holding a 5.702% stake in the company. This adjustment in voting rights reflects Maven’s increased influence in Verici Dx’s strategic decisions, potentially impacting the company’s future direction and stakeholder interests.
More about Verici Dx Plc
Verici Dx Plc operates within the medical diagnostics industry, focusing on the development of advanced tests for organ transplant patients. The company specializes in creating diagnostic solutions that aim to improve patient outcomes by predicting and monitoring immune responses to transplants.
YTD Price Performance: -58.12%
Average Trading Volume: 1,404,840
Technical Sentiment Signal: Buy
Current Market Cap: £3.94M
Learn more about VRCI stock on TipRanks’ Stock Analysis page.